Early COVID Shots May Have Been Less Potent Than Expected

(MedPage Today) -- Some early commercial batches of the Pfizer/BioNTech COVID-19 vaccine had less intact mRNA than expected, according to leaked documents that raise concerns about the firms' quality assurance monitoring.
A cyberattack on the...